Sunday, February 12, 2017 9:48:48 PM
There is no evidence that the studies have been challenged. On the contrary, the preclinical testing and double blind placebo controlled 6 month study in which Sucanon outperformed Glyburide was reviewed by the Mexican and Peruvian governments and formed the basis for approval of Sucanon. In fact for all your misrepresentation of an FDA ban, FDA states in their response letter:
1. Sucanon is considered a drug per the food and drug act
2. Sucanon has been subject to "substantial clinical investigations" directly citing the published studies
3. They did not review safety and efficacy data at all
4. Sucanon would have to be submitted as an investigational new drug application
In addition, your implication in a long ago post that you found information on Sucanon from a list of criminal investigations, that information has been debunked, as has the modified Consumer Reports article that was falsely made to appear that the company was warned for illegal marketing.
As a reminder, I post publicly verifiable information to back up each and every one of my claimed facts.
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM